These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 1655740)

  • 1. Oncostatin M up-regulates low density lipoprotein receptors in HepG2 cells by a novel mechanism.
    Grove RI; Mazzucco CE; Radka SF; Shoyab M; Kiener PA
    J Biol Chem; 1991 Sep; 266(27):18194-9. PubMed ID: 1655740
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Induction of Egr-1 by oncostatin M precedes up-regulation of low density lipoprotein receptors in HepG2 cells.
    Liu J; Shoyab M; Grove RI
    Cell Growth Differ; 1993 Jul; 4(7):611-6. PubMed ID: 8398902
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Macrophage-derived factors increase low density lipoprotein uptake and receptor number in cultured human liver cells.
    Grove RI; Mazzucco C; Allegretto N; Kiener PA; Spitalny G; Radka SF; Shoyab M; Antonaccio M; Warr GA
    J Lipid Res; 1991 Dec; 32(12):1889-97. PubMed ID: 1816320
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oncostatin M induces tyrosine phosphorylation in endothelial cells and activation of p62yes tyrosine kinase.
    Schieven GL; Kallestad JC; Brown TJ; Ledbetter JA; Linsley PS
    J Immunol; 1992 Sep; 149(5):1676-82. PubMed ID: 1324279
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oncostatin M activates low density lipoprotein receptor gene transcription in sterol-repressed liver cells.
    Liu J; Grove RI; Vestal RE
    Cell Growth Differ; 1994 Dec; 5(12):1333-8. PubMed ID: 7696181
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumor necrosis factor up-regulates expression of low-density lipoprotein receptors on HepG2 cells.
    Liao W; Florén CH
    Hepatology; 1993 May; 17(5):898-907. PubMed ID: 8387950
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Up-regulation of low density lipoprotein receptor by a novel isobenzofranone derivative, MD-700.
    Murakami S; Nitanai I; Uchida S; Kondo-Ohta Y; Asami Y; Kondo K; Sato M; Kawashima A; Hara H; Tomisawa K; Mei HB; Xiang CZ
    Atherosclerosis; 1999 Oct; 146(2):281-90. PubMed ID: 10532684
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Complete down-regulation of low-density-lipoprotein-receptor activity in the human hepatoma cell line Hep G2 by beta-migrating very-low-density lipoprotein and non-lipoprotein cholesterol. Different cellular regulatory pools of cholesterol.
    Kamps JA; van Berkel TJ
    Eur J Biochem; 1992 Jun; 206(3):973-8. PubMed ID: 1318843
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interaction of apolipoprotein B-containing lipoprotein secreted by Hep G2 cells with receptors for low-density lipoprotein.
    Fuki IV; Menschikov GB; Menschikowski M; Adamova IYu ; Repin VS
    Biochim Biophys Acta; 1991 Nov; 1086(2):237-40. PubMed ID: 1657183
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oncostatin M is a mitogen for rabbit vascular smooth muscle cells.
    Grove RI; Eberhardt C; Abid S; Mazzucco C; Liu J; Kiener P; Todaro G; Shoyab M
    Proc Natl Acad Sci U S A; 1993 Feb; 90(3):823-7. PubMed ID: 8430092
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulation of cell growth by recombinant oncostatin M.
    Horn D; Fitzpatrick WC; Gompper PT; Ochs V; Bolton-Hansen M; Zarling J; Malik N; Todaro GJ; Linsley PS
    Growth Factors; 1990; 2(2-3):157-65. PubMed ID: 2160258
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Specific interaction of Egr1 and c/EBPbeta leads to the transcriptional activation of the human low density lipoprotein receptor gene.
    Zhang F; Lin M; Abidi P; Thiel G; Liu J
    J Biol Chem; 2003 Nov; 278(45):44246-54. PubMed ID: 12947119
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human ATP-binding cassette transporter-2 (ABCA2) positively regulates low-density lipoprotein receptor expression and negatively regulates cholesterol esterification in Chinese hamster ovary cells.
    Davis W; Boyd JT; Ile KE; Tew KD
    Biochim Biophys Acta; 2004 Jul; 1683(1-3):89-100. PubMed ID: 15238223
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cyclosporine inhibits catabolism of low-density lipoproteins in HepG2 cells by about 25%.
    Rayyes OA; Wallmark A; Florén CH
    Hepatology; 1996 Sep; 24(3):613-9. PubMed ID: 8781333
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of net HepG2 cell apolipoprotein B secretion by the citrus flavonoid naringenin involves activation of phosphatidylinositol 3-kinase, independent of insulin receptor substrate-1 phosphorylation.
    Borradaile NM; de Dreu LE; Huff MW
    Diabetes; 2003 Oct; 52(10):2554-61. PubMed ID: 14514640
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Upregulation of low density lipoprotein receptor by gemfibrozil, a hypolipidemic agent, in human hepatoma cells through stabilization of mRNA transcripts.
    Goto D; Okimoto T; Ono M; Shimotsu H; Abe K; Tsujita Y; Kuwano M
    Arterioscler Thromb Vasc Biol; 1997 Nov; 17(11):2707-12. PubMed ID: 9409246
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Induction of low density lipoprotein receptor (LDLR) transcription by oncostatin M is mediated by the extracellular signal-regulated kinase signaling pathway and the repeat 3 element of the LDLR promoter.
    Li C; Kraemer FB; Ahlborn TE; Liu J
    J Biol Chem; 1999 Mar; 274(10):6747-53. PubMed ID: 10037774
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Staurosporine inhibits a tyrosine protein kinase in human hepatoma cell membranes.
    Fallon RJ
    Biochem Biophys Res Commun; 1990 Aug; 170(3):1191-6. PubMed ID: 2167672
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cyclic AMP decreases LDL catabolism and cholesterol synthesis in the human hepatoma cell line HepG2.
    Maziere C; Maziere JC; Salmon S; Auclair M; Mora L; Moreau M; Polonovski J
    Biochem Biophys Res Commun; 1988 Oct; 156(1):424-31. PubMed ID: 2845980
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oncostatin M receptor-mediated signal transduction is negatively regulated by SOCS3 through a receptor tyrosine-independent mechanism.
    Stross C; Radtke S; Clahsen T; Gerlach C; Volkmer-Engert R; Schaper F; Heinrich PC; Hermanns HM
    J Biol Chem; 2006 Mar; 281(13):8458-68. PubMed ID: 16459330
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.